Retreatment of Chronic Hepatitis C Infection: Real-World Regimens and Outcomes From National Treatment Programs in Three Low- and Middle-Income Countries

Access to recommended second-line treatments is limited for patients who fail initial hepatitis C virus (HCV) therapy in low- and middle-income countries. Alternative regimens and associated outcomes are not well understood. Through a pooled analysis of national program data in Egypt, Georgia, and M...

Descripción completa

Detalles Bibliográficos
Autores principales: Boeke, Caroline E, Hiebert, Lindsey, Waked, Imam, Tsertsvadze, Tengiz, Sharvadze, Lali, Butsashvili, Maia, Zakalashvili, Mamuka, Naing, Win, Gupta, Neil, Kateera, Fredrick, McClure, Craig, Ward, John W, Ramers, Christian B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835629/
https://www.ncbi.nlm.nih.gov/pubmed/34014252
http://dx.doi.org/10.1093/cid/ciab461
Descripción
Sumario:Access to recommended second-line treatments is limited for patients who fail initial hepatitis C virus (HCV) therapy in low- and middle-income countries. Alternative regimens and associated outcomes are not well understood. Through a pooled analysis of national program data in Egypt, Georgia, and Myanmar, we observed SVR rates >90% for alternative retreatment regimens.

Ejemplares similares